{"denoms":[{"counts":[{"groupId":"BG000","value":"159"},{"groupId":"BG001","value":"154"},{"groupId":"BG002","value":"313"}],"units":"Participants"}],"groups":[{"description":"Within 17 days (preferably within 14 days) days after IV over 30 minutes on day 1. Treatment repeats every 3 weeks for 18 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood throughout the study and MRI or CT on study.\n\nBiospecimen Collection: Undergo collection of blood\n\nComputed Tomography: Undergo CT\n\nMagnetic Resonance Imaging: Undergo MRI\n\nPembrolizumab: Given IV\n\nTherapeutic Conventional Surgery: Undergo surgery","id":"BG000","title":"Arm I (Adjuvant Pembrolizumab)"},{"description":"Patients receive pembrolizumab IV over 30 minutes on day 1 every 3 weeks for 3 cycles, then undergo surgery within 3 weeks. Within 84 days, patients receive pembrolizumab IV over 30 minutes every 3 weeks for 15 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood throughout the study and MRI or CT on study.\n\nBiospecimen Collection: Undergo collection of blood\n\nComputed Tomography: Undergo CT\n\nMagnetic Resonance Imaging: Undergo MRI\n\nPembrolizumab: Given IV\n\nTherapeutic Conventional Surgery: Undergo surgery","id":"BG001","title":"Arm II (Adjuvant and Neoadjuvant Pembrolizumab)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"22","upperLimit":"88","value":"62"},{"groupId":"BG001","lowerLimit":"19","upperLimit":"90","value":"64"},{"groupId":"BG002","lowerLimit":"19","upperLimit":"90","value":"64"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"62"},{"groupId":"BG002","value":"110"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"111"},{"groupId":"BG001","value":"92"},{"groupId":"BG002","value":"203"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"13"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"136"},{"groupId":"BG002","value":"287"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"13"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"150"},{"groupId":"BG001","value":"141"},{"groupId":"BG002","value":"291"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"14"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"125"},{"groupId":"BG001","value":"113"},{"groupId":"BG002","value":"238"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"39"},{"groupId":"BG002","value":"72"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"title":"2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"title":"Missing/Not Reported"}],"description":"Zubrod's performance-status scores range from 0 to 5, with higher scores indicating greater disability; a score of 0 indicates that the participant is fully active, 1 that the patient is restricted in strenuous activity but is ambulatory, and 2 that the participant is unable to work but is ambulatory and capable of self-care and up and about more than 50% of waking hours.","paramType":"COUNT_OF_PARTICIPANTS","title":"Zubrod Performance Status Score","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"138"},{"groupId":"BG001","value":"132"},{"groupId":"BG002","value":"270"}]}],"title":"Low or Normal"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"43"}]}],"title":"High"}],"description":"LDH denotes lactate dehydrogenase.","paramType":"COUNT_OF_PARTICIPANTS","title":"LDH Level","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"62"},{"groupId":"BG002","value":"126"}]}],"title":"IIIB"},{"categories":[{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"69"},{"groupId":"BG002","value":"143"}]}],"title":"IIIC"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"19"}]}],"title":"IIID"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"25"}]}],"title":"IV"}],"description":"Stages are defined according to the American Joint Committee on Cancer 'Cancer Staging Manual', 8th edition.","paramType":"COUNT_OF_PARTICIPANTS","title":"Disease Stage","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"153"},{"groupId":"BG001","value":"143"},{"groupId":"BG002","value":"296"}]}],"title":"Cutaneous or Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"}]}],"title":"Acral"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"4"}]}],"title":"Mucosal"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}]}],"title":"Missing/Not Reported"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Primary Melanoma Subtype","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"102"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"108"}]}],"title":"No"},{"categories":[{"measurements":[{"groupId":"BG000","value":"55"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"101"}]}],"title":"Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}]}],"title":"Missing/Not Reported"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ulceration","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"38"},{"groupId":"BG001","value":"41"},{"groupId":"BG002","value":"79"}]}],"title":"Mutated"},{"categories":[{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"62"},{"groupId":"BG002","value":"126"}]}],"title":"Wild-type"},{"categories":[{"measurements":[{"groupId":"BG000","value":"57"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"108"}]}],"title":"Unknown"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"BRAF Mutation Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"4"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"158"},{"groupId":"BG001","value":"151"},{"groupId":"BG002","value":"309"}]}],"title":"No"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Previous BRAF and MEK Adjuvant Therapy","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"158"},{"groupId":"BG001","value":"152"},{"groupId":"BG002","value":"310"}]}],"title":"No"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Previous Radiotherapy","unitOfMeasure":"Participants"}]}